Page 4 - மருந்து ஒப்புதல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
SAS Global Forum: SAS auch bei AWS und Google Cloud
computerwelt.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from computerwelt.at Daily Mail and Mail on Sunday newspapers.
Faktencheck: Sind Kinder an der Corona-Impfung gestorben?
kurier.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kurier.at Daily Mail and Mail on Sunday newspapers.
Apr 30, 2021 6:40pm
The landmark decision in CKD comes after Farxiga nabbed a first-in-class nod in heart failure patients last year.
AstraZeneca s diabetes med Farxiga stormed the heart failure market with a first-in-class approval last year and in chronic kidney disease, it just left would-be rival Jardiance in the dust.
The FDA late Friday approved Farxiga, also known as dapagliflozin, to treat chronic kidney disease even in patients without diabetes.
With that CKD approval in hand, Farxiga has cemented its lead against Eli Lilly and Boehringer Ingelheim’s SGLT2 rival Jardiance, which isn t expecting data from its kidney disease outcomes trial till 2022.
EQS-News: Relief veröffentlicht Finanzergebnisse für das Geschäftsjahr 2020 und | Newsticker
fuw.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fuw.ch Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global laboratory gas generators market is projected to reach USD 686 million by 2026 from USD 353 million in 2021, at a CAGR of 14.2% during the forecast period.
The growth of the laboratory gas generators market is primarily driven by the growing importance of analytical techniques in drug and food approval processes, rising food safety concerns, increasing adoption of laboratory gas generators owing to their various advantages over conventional gas cylinders, growing demand for hydrogen gas as an alternative to helium, and the increasing R&D spending in target industries.
On the other hand, reluctance shown by lab users in terms of replacing conventional gas supply methods with modern laboratory gas generators and the availability of refurbished products are the major factors expected to hamper the growth of this market.